Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

ARAV

Aravive (ARAV)

Aravive Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:ARAV
FechaHoraFuenteTítuloSímboloCompañía
08/02/202406:00Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:ARAVAravive Inc
01/02/202423:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ARAVAravive Inc
29/01/202415:17Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:ARAVAravive Inc
29/01/202415:10Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:ARAVAravive Inc
29/01/202415:06Edgar (US Regulatory)Form 25 - Notification of the removal from listing and registration of matured, redeemed or retired securitiesNASDAQ:ARAVAravive Inc
17/01/202415:22Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ARAVAravive Inc
17/01/202415:09GlobeNewswire Inc.Aravive, Inc. to Delist from The Nasdaq Stock MarketNASDAQ:ARAVAravive Inc
09/11/202315:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ARAVAravive Inc
22/09/202316:04Edgar (US Regulatory)Form DEFR14A - Revised definitive proxy soliciting materialsNASDAQ:ARAVAravive Inc
05/09/202315:05Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ARAVAravive Inc
25/08/202306:30Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:ARAVAravive Inc
24/08/202316:18Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:ARAVAravive Inc
14/08/202315:06Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:ARAVAravive Inc
20/06/202315:12Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:ARAVAravive Inc
05/06/202315:07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ARAVAravive Inc
10/05/202315:08Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ARAVAravive Inc
01/05/202311:50Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:ARAVAravive Inc
19/04/202315:32Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ARAVAravive Inc
11/04/202315:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARAVAravive Inc
11/04/202315:07Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ARAVAravive Inc
15/03/202306:07Edgar (US Regulatory)Annual Report (10-k)NASDAQ:ARAVAravive Inc
14/02/202315:02Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ARAVAravive Inc
28/12/202215:01Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:ARAVAravive Inc
29/11/202207:04Dow Jones NewsAravive Shares Rise Premarket on FDA Fast-Track Designation for BatiraxceptNASDAQ:ARAVAravive Inc
17/11/202215:06Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:ARAVAravive Inc
10/11/202209:15TipRanksH.C. Wainwright Sticks to Their Buy Rating for Aravive (ARAV)NASDAQ:ARAVAravive Inc
28/10/202215:12Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:ARAVAravive Inc
10/10/202215:05GlobeNewswire Inc.Aravive Receives Third Development Milestone from 3D MedicinesNASDAQ:ARAVAravive Inc
26/09/202207:00GlobeNewswire Inc.Aravive to Participate in the Cantor Fitzgerald Oncology & HemOnc ConferenceNASDAQ:ARAVAravive Inc
06/09/202215:05GlobeNewswire Inc.Aravive to Participate in H.C. Wainwright 24th Annual Global Investment ConferenceNASDAQ:ARAVAravive Inc
 Showing the most relevant articles for your search:NASDAQ:ARAV

Su Consulta Reciente